Thanks, PL. My question is this: Why has MRK not even bothered to issue a PR from EASL as every other HCV company presenting data at the conference has done? Is the reticence for competitive reasons… or does it suggest that MRK doesn’t think MK-7009 is something worth getting exited about?
Market Data 
Markets 
AI
